IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | 1024天前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | 575天前
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | 757天前
European Economic News Preview: UK Inflation Data Due

European Economic News Preview: UK Inflation Data Due

Consumer prices data from the UK is the top economic news due on Wednesday, headlining a light day for the European economic news. At 2.00 am ET, the Office for National Statistics releases UK inflation data for August. Economists forecast consumer price inflation to remain unchanged at 3.8 percent.
RTTNews | 4小時4分鐘前
Australian Market Extends Early Losses In Mid-market

Australian Market Extends Early Losses In Mid-market

The Australian stock market is extending its early losses in mid-market moves on Wednesday, reversing the gains in the previous session, with the benchmark S&P/ASX 200 falling well below the 8,850 level, following the broadly negative cues from Wall Street overnight, with weakness in mining and financial stocks partially offset by gains in energy and technology stocks.
RTTNews | 4小時27分鐘前
Asian Markets Track Global Markets Lower

Asian Markets Track Global Markets Lower

Asian stock markets are trading mostly lower on Wednesday, following the broadly negative cues from global markets overnight, as traders fear the widely expected interest rate cut of a quarter point by the US Fed later in the day will be too little after recent US jobs and inflation numbers. They remain cautious and are reluctant to make significant moves ahead of the announcement.
RTTNews | 4小時31分鐘前